Letter from AL.Bloom to Dr.J.Holgate DHSS in relation to to material originating from the US and sold to Speywood Labs where it is relabelled. States that the material has passed the normal control processes for the UK. Reference made to inter-pharma who intend to market cut price Factor VIII obtained from Cutter Labs and Hyland and asks whether this material has been through the control mechanisms.